Who owns Abbvie?
- CUSIP Number: 00287Y959
Tip: Access positions for across all investors
Analyze quarterly positions in Abbvie with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abbvie stock
Who bought or sold Abbvie this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jpmorgan Chase & Co | 361k | $84M | 100% | Sep 2025 |
|
| IMC-Chicago | 353k | $81M | -29% | Dec 2025 |
|
| Simplex Trading | 308k | $71M | 11% | Sep 2025 |
|
| SG Americas Securities | 202k | $14k | -4% | Dec 2025 |
|
| Group One Trading | 80k | $18M | -34% | Sep 2025 |
|
| Hrt Financial | 68k | $16M | 82% | Sep 2025 |
|
| Gladius Capital Management | 56k | $13M | 82% | Dec 2025 |
|
| Maven Securities | 33k | $7.7M | 29% | Sep 2025 |
|
| Burns Matteson Capital Management | 1.4k | $54k | 100% | Dec 2025 |
|
| All Terrain Financial Advisors | 600.00 | $139k | 100% | Sep 2025 |
|
Who sold out of Abbvie?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| CenterStar Asset Management | Sep 2025 | 2.0k | $463k |